
QBench is a cloud-based Laboratory Information Management System (LIMS) designed to help laboratories manage samples, workflows, data, inventory, reporting, quality processes, and client interactions in one platform.
Labs use QBench to manage operations from order placement and sample processing through results and automated reporting. The platform is highly configurable, allowing laboratories to build workflows, define custom data fields, and automate processes around the way their lab operates.
QBench helps reduce manual work by connecting instruments, software, and other systems through file parsers and a robust API. These integrations can automate data transfer, reduce repetitive data entry, and lower the risk of transcription errors.
Key capabilities include sample and workflow management, configurable workflows and custom fields, workflow automation, instrument and system integrations, file parsing, API connectivity, inventory management, client portals, automated reporting, analytics, and integrated Quality Management System (QMS) capabilities.
QBench is designed to adapt as laboratory processes change. Teams can modify workflows, fields, and automations without relying heavily on custom development.
As a cloud-based platform, QBench brings laboratory data, workflows, automation, quality management, and reporting into one centralized system. Customers are also supported by a team that includes former bench scientists who understand laboratory workflows and provide guidance during implementation and ongoing use.
Learn more
SciSure is a Scientific Management Platform built to support the full range of laboratory operations for scientific organizations. It combines ELN, LIMS, and Health & Safety functionality, giving teams a single system to document experiments, track sample lineage, manage chemical inventory, and run structured, audit-ready compliance processes.
Instead of relying on disconnected systems, organizations get one governed platform that improves reproducibility, increases visibility into lab operations, and reduces risk as they scale.
Learn more
GPT-Rosalind
GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.
Learn more
Recursion
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
Learn more